Stephen Holland is named as a lobbyist on federal disclosure filings for 17 clients through Brownstein Hyatt Farber Schreck, LLP and 1 other registrant. The most recent filing naming them posted in November 2026. Issues reported include Health Issues, Pharmacy, Education and Manufacturing.
Filers must list covered executive or legislative branch positions held. As filed:
| Client | Registrant | Latest | Issues |
|---|---|---|---|
| IMMIX BIOPHARMA, INC. | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q4 2026 | Pharmacy, Health Issues |
| BECTON, DICKINSON AND COMPANY | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q3 2026 | Trade (domestic/foreign), Medicare/Medicaid, Health Issues |
| TOLMAR, INC. | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q3 2026 | Pharmacy |
| NOVARTIS | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q3 2026 | Health Issues |
| ELANCO ANIMAL HEALTH | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q3 2026 | Pharmacy, Tariff (miscellaneous tariff bills) |
| KYVERNA THERAPEUTICS, INC. | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q3 2026 | Pharmacy, Health Issues |
| NOVAVAX, INC. | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q3 2026 | Health Issues |
| GRINDR LLC | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q3 2026 | Health Issues |
| FERRING PHARMACEUTICALS INC. | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q3 2026 | Health Issues |
| ELI LILLY AND COMPANY | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q3 2026 | Pharmacy, Health Issues |
| CARDINAL HEALTH, INC. | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q3 2026 | Pharmacy, Health Issues |
| BAYLOR COLLEGE OF MEDICINE | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q3 2026 | Education |
| ASANA VOICES | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q3 2026 | Health Issues |
| CAREQUEST INSTITUTE FOR ORAL HEALTH, INC. | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q3 2026 | Health Issues |
| LONZA GROUP AG | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q2 2026 | Trade (domestic/foreign), Manufacturing |
| PIERRE FABRE PHARMACEUTICALS INC. | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q1 2026 | Pharmacy |
| VICTIMS OF STATE SPONSORED TERRORISM | CROWELL & MORING LLP | Q2 2025 | Government Issues |
| NOVAVAX, INC. | CROWELL & MORING LLP | Q2 2025 | Health Issues |
| BAYLOR COLLEGE OF MEDICINE | CROWELL & MORING LLP | Q2 2025 | Foreign Relations, Health Issues, Budget/Appropriations |
| LONZA GROUP AG | CROWELL & MORING LLP | Q2 2025 | Trade (domestic/foreign) |
| CARDINAL HEALTH, INC. | CROWELL & MORING LLP | Q1 2025 | Health Issues |
| Year | Clients | Registrants |
|---|---|---|
| 2026 | 15 | 1 |
| 2025 | 8 | 2 |
| Year | Items | Total |
|---|---|---|
| 2026 | 17 | $11K |
Pay is not disclosed for individual lobbyists. Filings do not confirm that records with the same name are one person, so this page may combine people who share the name Stephen Holland. See the Capitol Clarity rankings and method.